benefits of semaglutide for pcos CUAnschutz researchers have published a proof-of-concept study demonstrating that injectable may offer meaningful reproductive women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as PCOS. “Women with PMOS Semaglutide & Tirzepatide with PCOS:

Schuster, S

In contrast, those who switched to placebo regained significant weight, ending the study with only a -9.9% change from baseline

Yeteref Bet Pharmaceutical #MedicationMyths #SafeMedicine #PainkillerAwareness #HealthEducation To view or add a comment, sign in 27 followers

In vivo safety assessment Healthy mice received a topical application of OA-NPs@OA or free OA (at a high dose of 1 mg per mouse) to their shaved dorsal skin twice daily for 7 consecutive days

However, researchers are still studying whether there may also be additional effects related to vascular function, insulin sensitivity, kidney function, or other metabolic changes

However, this remains an area of active debate within the field